Latest Breaking News On - Chaim lebovits - Page 12 : comparemela.com

BrainStorm Cell Therapeutics Partners with NEALS, The ALS Association, and I AM ALS to Provide Public Access to Biospecimens from NurOwn s Phase 3 ALS Study

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today.

United statesJohn mullalyKuldip daveBrian wallachChaim lebovitsLisa guitermanJames berryAmyotrophic lateral sclerosis consortiumCalifornia institute for regenerative medicineBrainstorm cell therapeutics incLifesci advisorsDrug administrationNational ms societyEuropean medicines agencyBrainstorm cell therapeuticsStacy lindborg phd

BrainStorm Cell Therapeutics to Present at Biotech Showcase™ 2023

BrainStorm Cell Therapeutics to Present at Biotech Showcase™ 2023
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesChaim lebovitsLisa guitermanStacy lindborgBrainstorm cell therapeutics incCalifornia institute for regenerative medicineDrug administrationPrnewswire brainstorm cell therapeutics incHilton san francisco union squareNational ms societyEuropean medicines agencyStorm cell therapeuticsBiotech showcaseBallroom levelOrphan drugCalifornia institute

BrainStorm Cell Therapeutics Announces Promotion of Dr Stacy Lindborg to Co-Chief Executive Officer

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today.

United statesJohn mullalyRalph kernChaim lebovitsLisa guitermanStacy lindborgDevelopment officerCalifornia institute for regenerative medicineBrainstorm cell therapeutics incEli lilly companyLifesci advisorsMassachusetts down syndrome congressDrug administrationImunon incPrnewswire brainstorm cell therapeutics incNational ms society

BrainStorm Cell Therapeutics Announces Promotion of Dr Stacy Lindborg to Co-Chief Executive Officer

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today.

United statesJohn mullalyRalph kernChaim lebovitsLisa guitermanStacy lindborgDevelopment officerCalifornia institute for regenerative medicineBrainstorm cell therapeutics incEli lilly companyLifesci advisorsMassachusetts down syndrome congressDrug administrationImunon incPrnewswire brainstorm cell therapeutics incNational ms society

BrainStorm Cell Therapeutics Announces Type A Meeting with FDA Granted for NurOwn®

/PRNewswire/ BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today.

United statesJohn mullalyChaim lebovitsLisa guitermanCalifornia institute for regenerative medicineBrainstorm cell therapeutics incLifesci advisorsDrug administrationPrnewswire brainstorm cell therapeutics incAdvisory committee meetingNational ms societyEuropean medicines agencyResearch symposiaStorm cell therapeuticsNew biologics license applicationChief executive officer